TRH attenuates scopolamine-induced memory impairment in humans. - Wikidata - wikimedia - TriplyDB

TRH attenuates scopolamine-induced memory impairment in humans.

TRH attenuates scopolamine-induced memory impairment in humans.

http://www.wikidata.org/entity/Q41897125

about

S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies Human models as tools in the development of psychotropic drugs Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitor Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.Novel thyrotropin-releasing hormone analogs: a patent review.Pharmacological models in Alzheimer's disease research Pharmacotherapy of cognitive impairment in Alzheimer's disease: a review.Low-dose thyrotropin-releasing hormone effects in cognitively impaired alcoholics.Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats.Enterostatin (VPDPR) has anti-analgesic and anti-amnesic activities.Effects of a new thyrotropin releasing hormone analogue, YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats.Aniracetam improves behavioural responses and facilitates signal transduction in the rat brain.Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study.Alteration of hypothalamic-pituitary-thyroid axis function in non-small-cell lung cancer patients.Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats.The scopolamine model as a pharmacodynamic marker in early drug development.Behavioral and endocrine interactions between thyrotropin-releasing hormone and ethanol in normal human subjects.Behavioural effects of scopolamine and the TRH analogue RX77368 on radial arm maze performance in the rat.Specific memory and sedative effects of the benzodiazepine triazolam.Scopolamine-induced amnesia in humans: lack of effects of the benzodiazepine receptor antagonist β-carboline ZK 93426.The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers.

P2860

Q28205251-1AC74882-1D8F-462A-8F21-B88F496F714D Q30473426-90ECD131-D8B4-45AC-8085-01F1E0B98CB5 Q35040005-A3D95F0F-C89F-4546-9FDD-9663F3732E76 Q36860047-48A3861A-7E49-4930-B1C0-97E4D4815280 Q37278592-94B545D7-3C45-4D01-AF7D-C7FD2789EBAA Q37948109-A517B870-0C77-4C73-872B-59FC4391813D Q38578433-C4924F73-C3C3-489B-AAEC-238DC7489047 Q40552135-D2015448-1256-4972-8C12-BF88E750ECCF Q41072397-CB91E7B1-F9FD-4D14-848F-C6961BFCC04B Q42754120-BBB3EE36-231C-4076-AE24-C45E7E5417B7 Q43555928-EA4373FE-FC47-410D-B963-0F450BD495A3 Q45903014-F7DAA4C3-3200-435D-9A21-C9F8BD4C8FD7 Q48192489-7FC0BC48-824F-4084-B24F-33F6BAE414ED Q48281648-7022D834-3596-4CC0-94A3-CCB72741D4B2 Q48286902-FFD580B2-25DC-4519-84D7-786958AD5F84 Q50778512-1060F915-93B9-4BDA-9D50-CA67790D5849 Q50993429-B293141A-E352-45F7-9627-901AC8B7FB29 Q52047298-B7A5CC30-2146-4264-9C47-38824D0F66C1 Q52059122-B69740AE-2AAB-46A0-9BD3-A18CD14B0F67 Q52066319-FA2A9551-CFB3-4C09-8B64-AABC900D3BE7 Q52079352-227CFE1D-F31A-44B2-98E1-FFA4E792E56B Q52091302-BC37CFD5-A743-4CB1-B391-26411A312726

P2860

TRH attenuates scopolamine-induced memory impairment in humans.

http://www.wikidata.org/entity/Q41897125

description

1990 nî lūn-bûn

@nan

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

1990年论文

@zh

1990年论文

@zh-cn

name

TRH attenuates scopolamine-induced memory impairment in humans.

@en

type

label

TRH attenuates scopolamine-induced memory impairment in humans.

@en

prefLabel

TRH attenuates scopolamine-induced memory impairment in humans.

@en

P1433

Q41897125-7D325125-EE47-4898-AE62-7DE0999F6FB6

P1476

Q41897125-4CAE7D62-8E16-4A8A-B96B-471CCDBADDD1

P2093

Q41897125-0BA9972F-17B2-4156-9F0F-D0E967721C30

Q41897125-132F24B5-8B7C-49E7-8E0C-95609EFAA5CA

Q41897125-28AAAAC1-3291-4A61-B1EA-284C2EEA42C0

Q41897125-2933D4D2-1EE9-4456-8032-9E3B1E5436C8

Q41897125-2C8AD4F3-D1AD-4249-B673-D56F5521C718

Q41897125-3074BDF5-134D-4EAB-A0C6-52B32A8C48FD

Q41897125-6FA12519-1709-4589-A28E-27DCDFF7C705

P2860

Q41897125-095584AD-E6BD-4940-9924-443BDBC25655

Q41897125-0A7CADE2-85E4-47C7-8A8E-36C072B3C35B

Q41897125-0DA985BD-BC0D-4CC9-88E8-F19F120582AF

Q41897125-10F279B8-E3CA-467B-B363-E742A5DD7C68

Q41897125-32FB8F38-5137-4E86-BA36-4EE0E4AFF985

Q41897125-46CEA9E8-220B-4B19-B077-7B5B018DEC6D

Q41897125-4D820F7C-252B-4940-964C-996F84E6850B

Q41897125-51DFC486-4525-44A8-91B9-1975679B5433

Q41897125-5A12F04C-6BF8-4EC5-881F-CC5945C51129

Q41897125-64EA5167-122D-4AB9-959E-CF74A73D746A

P2888

Q41897125-7C9028CE-ABC2-45C6-B8BD-DF684F33C8F5

P304

Q41897125-779E37C5-E3BB-45FC-BDC2-0B17122ACB97

P31

Q41897125-6DE67011-FFFA-471D-96F9-9CB35E8CDF81

P356

Q41897125-EAA7007D-C82E-4554-A852-6C7F9BFE00BA

P433

Q41897125-604CB2A9-BEE6-4769-B14A-1F920175F113

P478

Q41897125-0FF0AFA3-B59A-465C-823E-E8BD58D1106C

P577

Q41897125-04CFC9E1-85E2-4F85-AE54-C2733E208114

P6179

Q41897125-848AA860-15F0-44CE-8E27-B35C5C2A5EEE

P698

Q41897125-98D12C9D-8AE4-4ED8-9AB0-DD664CD410F0

P356

P1433

Psychopharmacology

P1476

TRH attenuates scopolamine-induced memory impairment in humans.

@en

P2093

A M Mellow

http://www.w3.org/2001/XMLSchema#string

B A Lawlor

http://www.w3.org/2001/XMLSchema#string

H J Weingartner

http://www.w3.org/2001/XMLSchema#string

M R Cohen

http://www.w3.org/2001/XMLSchema#string

R M Cohen

http://www.w3.org/2001/XMLSchema#string

S E Molchan

http://www.w3.org/2001/XMLSchema#string

T Sunderland

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine

Blood pressure response to thyrotropin-releasing hormone in euthyroid subjects.

Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.

Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes.

Forms of memory failure.

Pharmacology of thyrotropin-releasing hormone.

Effects of thyrotropin releasing hormone, norepinephrine and acetylcholine on the activity of neurons in the hypothalamus, septum and cerebral cortex of the rat.

Pharmacologic modelling of Alzheimer's disease.

On the neuropharmacology of thyrotropin releasing hormone (TRH).

P2888

P304

84-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF02245795

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

1990-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038304947

http://www.w3.org/2001/XMLSchema#string

P698

2104988

http://www.w3.org/2001/XMLSchema#string